Metformin and cancer therapy.

Current opinion in oncology

Volumn 24, Issue 1, 2012, Pages 103-108

  Bost, Frédéric ^a   Sahra, Issam Ben ^b   Le Marchand Brustel, Yannick ^b   Tanti, Jean François ^b  

^a CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN;

ANIMAL; CELL PROLIFERATION; DRUG EFFECT; HUMAN; METABOLISM; MOUSE; NEOPLASM; REVIEW; TUMOR CELL LINE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; MICE; NEOPLASMS;

MLCS; MLOWN;

EID: 85027954141     PISSN: None     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/cco.0b013e32834d8155     Document Type: Review

References (0)